SEO URLwww.firestrike.ai/deals/nivian-lifesciences-beta-drugs-acquisition-2026
acquisitionAnnounced · Jan 27, 2026In-Vitro Fertilisation (IVF) therapySource · AdvertisementsArticle · Factual
Beta Drugs acquires Nivian Lifesciences
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
—
Target
Nivian Lifesciences
Acquirer
Beta Drugs
Financial Stake
Status
Announced
Beta Drugs agreed to acquire Nivian Lifesciences. Reported deal value: Undisclosed. Status: Announced. Sector: In-Vitro Fertilisation (IVF) therapy. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-01-27. Figures and status may change as filings and press coverage update.
Share on Telegram Share on Facebook Mumbai: Beta Drugs Limited has entered into a definitive agreement to acquire 66.09% stake in Nivian Lifesciences Private Limited
Deal timeline
Announced
Jan 27, 2026 · health.economictimes.indiatimes.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in In-Vitro Fertilisation (IVF) therapy. Figures and status may change as sources update.
Sources: health.economictimes.indiatimes.com · Primary article · FireStrike proprietary index